Araf Y, Faruqui NA, Anwar S et al (2021) SARS-CoV-2: a new dimension to our understanding of coronaviruses. Int Microbiol 24:19–24. https://doi.org/10.1007/s10123-020-00152-y
Article
CAS
PubMed
Google Scholar
(2021) Coronavirus Update (Live): 108,380,746 cases and 2,380,746 deaths from COVID-19 virus pandemic—Worldometer. Worldometers.info. https://www.worldometers.info/coronavirus/
Cascella M, Rajnik M, Aleem A, Dulebohn SC, Di Napoli R (2022) Features, evaluation, and treatment of Coronavirus (COVID-19). In: StatPearls. StatPearls Publishing, Treasure Island. PMID: 32150360.
Cui J, Li F, Shi ZL (2019) Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol 17(3):181–192. https://doi.org/10.1038/s41579-018-0118-9
Article
CAS
PubMed
Google Scholar
Ejaz H, Alsrhani A, Zafar A, Javed H, Junaid K, Abdalla A et al (2020) COVID-19 and comorbidities: deleterious impact on infected patients. J Infect Public Health 13(12):1833–1839. https://doi.org/10.1016/j.jiph.2020.07.014
Article
PubMed
PubMed Central
Google Scholar
Aouissi H, Belhaouchet I (2021) What about rheumatic diseases and COVID-19? New Microbes New Infect 41:100846. https://doi.org/10.1016/j.nmni.2021.100846
Article
CAS
PubMed
PubMed Central
Google Scholar
Cox L, Bellantuono I, Lord J, Sapey E, Mannick J, Partridge L et al (2020) Tackling immunosenescence to improve COVID-19 outcomes and vaccine response in older adults. Lancet Healthy Longevity 1(2):e55–e57. https://doi.org/10.1016/S2666-7568(20)30011-8
Article
PubMed
Google Scholar
Genebat M, Tarancón-Díez L, Pablo-Bernal R, Calderón A, Muñoz-Fernández M, Leal M (2021) Coronavirus Disease (COVID-19): a perspective from immunosenescence. Aging Dis 12(1):3. https://doi.org/10.14336/AD.2020.0831
Article
PubMed
PubMed Central
Google Scholar
Jones L (2020) Coronavirus symptoms day-by-day—when to expect signs of the killer bug to strike. The US Sun. https://www.the-sun.com/news/554654/coronavirus-symptoms-day-by-day-when-to-expect-signs-of-killer-bug-to-strike/
(2020) How Coronavirus symptoms start, and what you can expect each day. IFLScience. https://www.iflscience.com/health-and-medicine/a-daybyday-breakdown-of-coronavirus-symptoms-shows-how-the-disease-covid19-goes-from-bad-to-worse/
(2020) A day-by-day breakdown of coronavirus symptoms shows how the disease COVID-19 goes from bad to worse. Business Insider. https://www.businessinsider.com/coronavirus-covid19-day-by-day-symptoms-patients-2020-2
Rahman A, Tabassum T, Araf Y, Al Nahid A, Ullah MA, Hosen MJ (2021) Silent hypoxia in COVID-19: pathomechanism and possible management strategy. Mol Biol Rep 48(4):3863–3869. https://doi.org/10.1007/s11033-021-06358-1
Article
CAS
PubMed
PubMed Central
Google Scholar
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Yu T (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The lancet 395(10223):507–513. https://doi.org/10.1016/S0140-6736(20)30211-7
Article
CAS
Google Scholar
Xu X, Wu X, Jiang X, Xu K, Ying L, Ma C et al (2019) Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ 2020:m606. https://doi.org/10.1136/bmj.m606
Article
Google Scholar
Coronavirus Disease 2019 (COVID-19) (2020). Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-nCoV/hcp/infection-control.html
Atherton M (2020) Coronavirus warning—the 'extremely common' symptom of COVID-19 you may be ignoring. Express.co.uk. https://www.express.co.uk/life-style/health/1301286/coronavirus-symptoms-signs-covid-19-infection-muscle-aches
Buist A (2003) Similarities and differences between asthma and chronic obstructive pulmonary disease: treatment and early outcomes. Eur Respir J 21(Supplement 39):30S – 35s. https://doi.org/10.1183/09031936.03.00404903
Article
Google Scholar
Lemanske RF Jr, Busse WW (2010) Asthma: clinical expression and molecular mechanisms. J Allergy Clin Immunol 125(2):S95-102. https://doi.org/10.1016/j.jaci.2009.10.047
Article
PubMed
PubMed Central
Google Scholar
Rettner R (2020) Asthma: causes, symptoms & treatment. livescience.com. https://www.livescience.com/41264-asthma-symptoms-treatment.html
(2020) Learn how to take control of asthma. Centers for Disease Control and Prevention. https://www.cdc.gov/asthma/faqs.htm#:~:text=It%20is%20one%20of%20the,when%20something%20bothers%20your%20lungs.
Martinez F (2006) Genes, environments, development, and asthma: a reappraisal. Eur Respir J 29(1):179–184. https://doi.org/10.1183/09031936.00087906
Article
CAS
Google Scholar
(2020) Asthma: types, causes, and diagnosis. Medicalnewstoday.com. https://www.medicalnewstoday.com/articles/323523#types
(2020) Asthma. Physiopedia. https://www.physio-pedia.com/Asthma
(2018) Global Health Estimates 2016: disease burden by cause, age, sex, by country and by region, 2000–2016. World Health Organization, Geneva
(2020) Asthma stages: definitions, symptoms, and treatments. Medicalnewstoday.com. https://www.medicalnewstoday.com/articles/324461
(2020) What is asthma?. HealthyChildren.org. https://www.healthychildren.org/English/health-issues/conditions/allergies-asthma/Pages/What-is-Asthma.aspx
(2020) Asthma statistics | British Lung Foundation. Statistics.blf.org.uk. https://statistics.blf.org.uk/asthma
(2020) How to distinguish allergy and asthma symptoms from COVID-19. https://news.childrensmercy.org/good-day-kansas-how-to-distinguish-allergy-and-asthma-symptoms-from-covid-19/
(2020) Coronavirus (COVID-19): what people with asthma need to know. Asthma and Allergy Foundation of America. https://community.aafa.org/blog/coronavirus-2019-ncov-flu-what-people-with-asthma-need-to-know
(2020) Coronavirus vs. asthma: how to tell the difference? | Asthma Center. Asthma Center. https://www.asthmacenter.com/asthma-vs-coronavirus-tell-difference/
Braciale TJ, Sun J, Kim TS (2012) Regulating the adaptive immune response to respiratory virus infection. Nat Rev Immunol 12(4):295–305. https://doi.org/10.1038/nri3166
Article
CAS
PubMed
PubMed Central
Google Scholar
Bosch BJ, van der Zee R, de Haan CA, Rottier PJ (2003) The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. J Virol 77(16):8801–8811. https://doi.org/10.1128/jvi.77.16.8801-8811.2003
Article
CAS
PubMed
PubMed Central
Google Scholar
Zou X, Chen K, Zou J, Han P, Hao J, Han Z (2020) Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front Med 14(2):185–192. https://doi.org/10.1007/s11684-020-0754-0
Article
PubMed
Google Scholar
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395(10223):497–506. https://doi.org/10.1016/S0140-6736(20)30183-5
Article
CAS
PubMed
PubMed Central
Google Scholar
Li G, Fan Y, Lai Y, Han T, Li Z, Zhou P et al (2020) Coronavirus infections, and immune responses. J Med Virol 92(4):424–432. https://doi.org/10.1002/jmv.25685
Article
CAS
PubMed
PubMed Central
Google Scholar
de Wilde A, Snijder E, Kikkert M, van Hemert M (2017) Host factors in Coronavirus replication. In: Roles of host gene and non-coding RNA expression in virus infection, pp 1–42. https://doi.org/10.1007/82_2017_25
Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, Xie C, Ma K, Shang K, Wang W, Tian DS (2020) Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis 71(15):762–768. https://doi.org/10.1093/cid/ciaa248
Article
CAS
PubMed
Google Scholar
Islam H, Rahman A, Masud J, Shweta DS, Araf Y, Ullah M, Sium A, Muktadir S, Sarkar B (2020) A generalized overview of SARS-CoV-2: where does the current knowledge stand? Electron J Gen Med 17(6):em251. https://doi.org/10.29333/ejgm/8258
Article
CAS
Google Scholar
Tabassum T, Rahman A, Araf Y, Ullah MA, Hosen MJ (2021) Prospective selected biomarkers in COVID-19 diagnosis and treatment. Biomark Med 15(15):1435–1449. https://doi.org/10.2217/bmm-2021-0038
Article
CAS
PubMed
Google Scholar
Stevenson D, Szczeklik A (2006) Clinical, and pathologic perspectives on aspirin sensitivity and asthma. J Allergy Clin Immunol 118(4):773–786. https://doi.org/10.1016/j.jaci.2006.07.024
Article
CAS
PubMed
Google Scholar
Agache I, Akdis C (2016) Endotypes of allergic diseases and asthma: an essential step in building blocks for the future of precision medicine. Allergol Int 65(3):243–252. https://doi.org/10.1016/j.alit.2016.04.011
Article
CAS
PubMed
Google Scholar
Akbari O, Faul J, Hoyte E, Berry G, Wahlström J, Kronenberg M et al (2006) CD4+ invariant T-cell–receptor+ natural killer T cells in bronchial asthma. N Engl J Med 354(11):1117–1129. https://doi.org/10.1056/NEJMoa053614
Article
CAS
PubMed
Google Scholar
Peters-Golden M (2004) The alveolar macrophage. Am J Respir Cell Mol Biol 31(1):3–7. https://doi.org/10.1165/rcmb.f279
Article
CAS
PubMed
Google Scholar
Leckie M, Brinke A, Khan J, Diamant Z, O’Connor B, Walls C et al (2000) Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 356(9248):2144–2148. https://doi.org/10.1016/S0140-6736(00)03496-6
Article
CAS
PubMed
Google Scholar
Kuipers H, Lambrecht B (2004) The interplay of dendritic cells, Th2 cells, and regulatory T cells in asthma. Curr Opin Immunol 16(6):702–708. https://doi.org/10.1016/j.coi.2004.09.010
Article
CAS
PubMed
Google Scholar
Liu S, Zhi Y, Ying S (2020) COVID-19 and asthma: reflection during the pandemic. Clin Rev Allergy Immunol 59:78–88. https://doi.org/10.1007/s12016-020-08797-3
Article
CAS
PubMed
PubMed Central
Google Scholar
Holgate S, Casale T, Wenzel S, Bousquet J, Deniz Y, Reisner C (2005) The anti-inflammatory effects of omalizumab confirm IgE’s central role in allergic inflammation. J Allergy Clin Immunol 115(3):459–465. https://doi.org/10.1016/j.jaci.2004.11.053
Article
CAS
PubMed
Google Scholar
Zhu Z, Hasegawa K, Ma B, Fujiogi M, Camargo CA Jr, Liang L (2020) Association of asthma and its genetic predisposition with the risk of severe COVID-19. J Allergy Clin Immunol 146(2):327–329. https://doi.org/10.1016/j.jaci.2020.06.001
Article
CAS
PubMed
PubMed Central
Google Scholar
Lombardi C, Gani F, Berti A, Comberiati P, Peroni D, Cottini M (2021) Asthma and COVID-19: a dangerous liaison? Asthma Res Pract. https://doi.org/10.1186/s40733-021-00075-z
Article
PubMed
PubMed Central
Google Scholar
(2020) Non-allergic asthma linked with increased risk of severe COVID-19. News. https://www.hsph.harvard.edu/news/features/non-allergic-asthma-linked-with-increased-risk-of-severe-covid-19/
Docherty AB, Harrison EM, Green CA, Hardwick HE, Pius R, Norman L, Holden KA, Read JM, Dondelinger F, Carson G, Merson L, Lee J, Plotkin D, Sigfrid L, Halpin S, Jackson C, Gamble C, Horby PW, Nguyen-Van-Tam JS, Ho A, Russell CD, Dunning J, Openshaw PJ, Baillie JK, Semple MG, ISARIC4C investigators (2020) Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ 369:m1985. https://doi.org/10.1136/bmj.m1985
Article
PubMed
PubMed Central
Google Scholar
(220) Asthma and COVID-19: risks and management considerations—CEBM. CEBM. https://www.cebm.net/covid-19/asthma-and-covid-19-risks-and-management-considerations/
(2020) OpenSAFELY: factors associated with COVID-19 related hospital deaths in adult NHS patients, April 28, 2020. GOV.UK. https://www.gov.uk/government/publications/opensafely-factors-associated-with-covid-19-related-hospital-deaths-in-adult-nhs-patients-28-april-2020
Bialek S, Gierke R, Hughes M, McNamara L, Pilishvili T, Skoff T (2020) Coronavirus Disease 2019 in children—United States, February 12–April 2, 2020. MMWR Morb Mortal Wkly Rep 69(14):422–426. https://doi.org/10.15585/mmwr.mm6914e4
Article
PubMed Central
Google Scholar
(2020) COVID-19 and asthma: what patients need to know | AAAAI. The American Academy of Allergy, Asthma & Immunology. https://www.aaaai.org/conditions-and-treatments/library/asthma-library/covid-asthma
Reddy S (2020) How vulnerable are children to the new Coronavirus?. WSJ. https://www.wsj.com/articles/how-vulnerable-are-children-to-the-new-coronavirus-11583858781
Wu Z, McGoogan JM (2020) Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 323(13):1239–1242. https://doi.org/10.1001/jama.2020.2648
Article
CAS
PubMed
Google Scholar
Bhatraju PK, Ghassemieh BJ, Nichols M, Kim R, Jerome KR, Nalla AK, Greninger AL, Pipavath S, Wurfel MM, Evans L, Kritek PA (2020) Covid-19 in critically ill patients in the Seattle region—case series. N Engl J Med 382(21):2012–2022. https://doi.org/10.1056/NEJMoa2004500
Article
CAS
PubMed
Google Scholar
(2020) Reflecting on World Asthma Day in the era of COVID-19. The Lancet. Respiratory Medicine. https://doi.org/10.1016/S2213-2600(20)30184-3
Korean Society of Infectious Diseases; Korean Society of Pediatric Infectious Diseases; Korean Society of Epidemiology; Korean Society for Antimicrobial Therapy; Korean Society for Healthcare-associated Infection Control and Prevention; Korea Centers for Disease Control and Prevention (2020) Report on the epidemiological features of Coronavirus Disease 2019 (COVID-19) outbreak in the Republic of Korea from January 19 to March 2, 2020. J Korean Med Sci 35(10):e112. https://doi.org/10.3346/jkms.2020.35.e112
Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, Liu XQ, Chen RC, Tang CL, Wang T, Ou CQ (2020) Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. https://doi.org/10.1183/13993003.00547-2020
Article
PubMed
PubMed Central
Google Scholar
Chhiba K, Patel G, Vu T, Chen M, Guo A, Kudlaty E et al (2020) Prevalence and characterization of asthma in hospitalized and nonhospitalized patients with COVID-19. J Allergy Clin Immunol 146(2):307–314. https://doi.org/10.1016/j.jaci.2020.06.010
Article
CAS
PubMed
PubMed Central
Google Scholar
Hakim D (2020) Asthma is absent among top Covid-19 Risk factors, early data shows. The New York Times. https://www.nytimes.com/2020/04/16/health/coronavirus-asthma-risk.html
(2020) Asthma not common in COVID-19 patients who've died. MedicineNet. https://www.medicinenet.com/script/main/art.asp?articlekey=230442
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y (2020) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus—infected pneumonia in Wuhan. China Jama 323(11):1061–1069. https://doi.org/10.1001/jama.2020.1585
Article
CAS
PubMed
Google Scholar
Lupia T, Scabini S, Mornese Pinna S, Di Perri G, De Rosa F, Corcione S (2020) 2019 novel coronavirus (2019-nCoV) outbreak: a new challenge. J Glob Antimicrob Resist 21:22–27. https://doi.org/10.1016/j.jgar.2020.02.021
Article
PubMed
PubMed Central
Google Scholar
Halpin DM, Faner R, Sibila O, Badia JR, Agusti A (2020) Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection? Lancet Respir Med 8(5):436–438. https://doi.org/10.1016/S2213-2600(20)30167-3
Article
CAS
PubMed
PubMed Central
Google Scholar
Lee S, Son K, Han C, Jung J, Park S (2020) Impact of comorbid asthma on severity of coronavirus disease (COVID-19). Sci Rep. https://doi.org/10.1038/s41598-020-77791-8
Article
PubMed
PubMed Central
Google Scholar
Jackson DJ, Busse WW, Bacharier LB, Kattan M, O’Connor GT, Wood RA, Visness CM, Durham SR, Larson D, Esnault S, Ober C (2020) Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2. J Allergy Clin Immunol 146(1):203–206. https://doi.org/10.1016/j.jaci.2020.04.009
Article
CAS
PubMed
PubMed Central
Google Scholar
Chałubiński M, Gajewski A, Kowalski M (2020) The relationship between human coronaviruses, asthma and allergy—an unresolved dilemma. Clin Exp Allergy 50(10):1122–1126. https://doi.org/10.1111/cea.13718
Article
CAS
PubMed
Google Scholar
Beurnier A, Jutant E, Jevnikar M, Boucly A, Pichon J, Preda M et al (2020) Characteristics and outcomes of asthmatic patients with COVID-19 pneumonia who require hospitalisation. Eur Respir J 56(5):2001875. https://doi.org/10.1183/13993003.01875-2020
Article
CAS
PubMed
PubMed Central
Google Scholar
Carli G, Cecchi L, Stebbing J, Parronchi P, Farsi A (2020) Is asthma protective against COVID-19? Allergy. https://doi.org/10.1111/all.14426
Article
PubMed
Google Scholar
Ari A (2020) Practical strategies for a safe and effective delivery of aerosolized medications to patients with COVID-19. Respir Med 167:105987. https://doi.org/10.1016/j.rmed.2020.105987
Article
PubMed
PubMed Central
Google Scholar
Amirav I, Newhouse M (2020) Transmission of coronavirus by nebulizer: a serious, underappreciated risk. Can Med Assoc J 192(13):E346–E346. https://doi.org/10.1503/cmaj.75066
Article
CAS
Google Scholar
Global Initiative for Asthma—GINA. https://ginasthma.org/
Singanayagam A, Glanville N, Girkin J, Ching Y, Marcellini A, Porter J et al (2018) Corticosteroid suppression of anti-viral immunity increases bacterial loads and mucus production in COPD exacerbations. Nat Commun. https://doi.org/10.1038/s41467-018-04574-1
Article
PubMed
PubMed Central
Google Scholar
Yamaya M, Nishimura H, Deng X, Sugawara M, Watanabe O, Nomura K et al (2020) Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells. Respir Investig 58(3):155–168. https://doi.org/10.1016/j.resinv.2019.12.005
Article
PubMed
PubMed Central
Google Scholar
Matsuyama S, Kawase M, Nao N, Shirato K, Ujike M, Kamitani W et al (2020) The inhaled corticosteroid ciclesonide blocks coronavirus RNA replication by targeting viral NSP15. BioRxiv. https://doi.org/10.1101/2020.03.11.987016
Article
Google Scholar
Peters MC, Sajuthi S, Deford P, Christenson S, Rios CL, Montgomery MT, Woodruff PG, Mauger DT, Erzurum SC, Johansson MW, Denlinger LC (2020) COVID-19—related genes in sputum cells in asthma. Relationship to demographic features and corticosteroids. Am J Respir Crit Care Med 202(1):83–90. https://doi.org/10.1164/rccm.202003-0821OC
Article
CAS
PubMed
PubMed Central
Google Scholar
Hartmann-Boyce J, Gunnell J, Drake J, Otunla A, Suklan J, Schofield E, Kinton J, Inada-Kim M, Hobbs FR, Dennison P (2020) Asthma and COVID-19: review of evidence on risks and management considerations. BMJ Evid Based Med 26:195
Article
Google Scholar
Licskai C, Yang C, Ducharme F, Radhakrishnan D, Podgers D, Ramsey C et al (2020) Addressing therapeutic questions to help Canadian physicians optimize asthma management for their patients during the COVID-19 pandemic. Can J Respir Crit Care Sleep Med 4(2):73–76. https://doi.org/10.1080/24745332.2020.1754027
Article
Google Scholar
Akter F, Araf Y, Hosen MJ (2022) Corticosteroids for COVID-19: worth it or not? Mol Biol Rep 49:567–576. https://doi.org/10.1007/s11033-021-06793-0
Article
CAS
PubMed
Google Scholar
(2020) WHO welcomes preliminary results about dexamethasone use in treating critically ill COVID-19 patients. Who.int. https://www.who.int/news-room/detail/16-06-2020-who-welcomes-preliminary-results-about-dexamethasone-use-in-treating-critically-ill-covid-19-patients
Esquivel A, Busse WW, Calatroni A, Togias AG, Grindle KG, Bochkov YA, Gruchalla RS, Kattan M, Kercsmar CM, Khurana Hershey G, Kim H (2017) Effects of omalizumab on rhinovirus infections, illnesses, and exacerbations of asthma. Am J Respir Crit Care Med 196(8):985–992. https://doi.org/10.1164/rccm.201701-0120OC
Article
CAS
PubMed
PubMed Central
Google Scholar
Berings M, Karaaslan C, Altunbulakli C, Gevaert P, Akdis M, Bachert C et al (2017) Advances and highlights in allergen immunotherapy: on the way to sustained clinical and immunologic tolerance. J Allergy Clin Immunol 140(5):1250–1267. https://doi.org/10.1016/j.jaci.2017.08.025
Article
CAS
PubMed
Google Scholar
Passalacqua G, Canonica GW (2015) AIT (allergen immunotherapy): a model for the “precision medicine.” Clin Mol Allergy 13(1):1–4. https://doi.org/10.1186/s12948-015-0028-6
Article
CAS
Google Scholar
Halomares O, Martín-Fontecha M, Lauener R, Traidl-Hoffmann C, Cavkaytar O, Akdis M et al (2014) Regulatory T cells and immune regulation of allergic diseases: roles of IL-10 and TGF-β. Genes Immun 15(8):511–520. https://doi.org/10.1038/gene.2014.45
Article
CAS
Google Scholar
Bergman S (2022) COVID-19 treatment: investigational drugs and other therapies: introduction, antiviral agents, immunomodulators and other investigational therapies. Emedicine.medscape.com. https://emedicine.medscape.com/article/2500116-overview
Sheahan TP, Sims AC, Leist SR et al (2020) Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV. Nat Commun 11:222–222. https://doi.org/10.1038/s41467-019-13940-6
Article
CAS
PubMed
PubMed Central
Google Scholar
Brown AJ, Won JJ, Graham RL et al (2019) Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase. Antiviral Res 169:104541–104541. https://doi.org/10.1016/j.antiviral.2019.104541
Article
CAS
PubMed
PubMed Central
Google Scholar
Beigel J, Tomashek K, Dodd L, Mehta A, Zingman B, Kalil A et al (2020) Remdesivir for the treatment of Covid-19—final report. N Engl J Med 383(19):1813–1826. https://doi.org/10.1056/NEJMoa2007764
Article
CAS
PubMed
Google Scholar
Norrie J (2020) Remdesivir for COVID-19: challenges of underpowered studies. Lancet 395(10236):1525–1527. https://doi.org/10.1016/S0140-6736(20)31023-0
Article
CAS
PubMed
PubMed Central
Google Scholar
Vincent M, Bergeron E, Benjannet S, Erickson B, Rollin P, Ksiazek T et al (2005) Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. Virol J. https://doi.org/10.1186/1743-422X-2-69
Article
PubMed
PubMed Central
Google Scholar
Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M et al (2020) Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res 30(3):269–271. https://doi.org/10.1038/s41422-020-0282-0
Article
CAS
PubMed
PubMed Central
Google Scholar
Liu J, Cao R, Xu M, Wang X, Zhang H, Hu H et al (2020) Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro. Cell Discov. https://doi.org/10.1038/s41421-020-0156-0
Article
PubMed
PubMed Central
Google Scholar
Dean T, Dewey A, Bara A, Lasserson TJ, Walters EH (2003) Chloroquine as a steroid sparing agent for asthma. Cochrane Database Syst Rev 4:CD003275. https://doi.org/10.1002/14651858.CD003275
Article
Google Scholar
Lecuit M (2020) Chloroquine and COVID-19, where do we stand? Med Mal Infect 50(3):229–230. https://doi.org/10.1016/j.medmal.2020.03.004
Article
CAS
PubMed
PubMed Central
Google Scholar
Aouissi H, Ababsa M, Gaagai A (2021) Review of a controversial treatment method in the fight against COVID-19 with the example of Algeria. Bull Natl Res Centre. https://doi.org/10.1186/s42269-021-00550-w
Article
Google Scholar
Gautret P, Lagier J, Parola P, Hoang V, Meddeb L, Mailhe M et al (2020) Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents 56(1):105949. https://doi.org/10.1016/j.ijantimicag.2020.105949
Article
CAS
PubMed
PubMed Central
Google Scholar
Echeverría-Esnal D, Martin-Ontiyuelo C, Navarrete-Rouco M, De-Antonio Cuscó M, Ferrández O, Horcajada J et al (2020) Azithromycin in the treatment of COVID-19: a review. Expert Rev Anti Infect Ther 19(2):147–163. https://doi.org/10.1080/14787210.2020.1813024
Article
CAS
PubMed
Google Scholar
Shimabukuro T, Nair N (2021) Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine—United States, December 14–23, 2020. MMWR Morb Mortal Wkly Rep 70:46–51. https://doi.org/10.1001/jama.2021.0600
Article
CAS
Google Scholar
(2021) Can the COVID-19 vaccine worsen asthma symptoms?. Medicalnewstoday.com. https://www.medicalnewstoday.com/articles/asthma-covid-vaccine#asthma-and-covid-19
Cagigi A, Loré K (2021) Immune responses induced by mRNA vaccination in mice, monkeys and humans. Vaccines 9(1):61. https://doi.org/10.3390/vaccines9010061
Article
CAS
PubMed
PubMed Central
Google Scholar
Baraldo S, Papi A, Saetta M, Contoli M (2017) IFN-α/IFN-λ responses to respiratory viruses in paediatric asthma. Eur Respir J 49(3):1602489. https://doi.org/10.1183/13993003.02489-2016
Article
PubMed
Google Scholar
(2022) COVID-19 vaccine and asthma: what you need to know | Allergy & Asthma Network. Allergy & Asthma Network. https://allergyasthmanetwork.org/news/covid-vaccine-and-asthma/
(2020) 'Massive shortages': rural Australian pharmacies low on essential medications amid coronavirus | Coronavirus outbreak | The Guardian. http://Amp-theguardian-com.cdn.ampproject.org
(2020) FDA approves first generic of a commonly used albuterol inhaler to treat and prevent bronchospasm. US Food and Drug Administration. https://www.fda.gov/news-events/press-announcements/fda-approves-first-generic-commonly-used-albuterol-inhaler-treat-and-prevent-bronchospasm
Society C (2020) Paediatric asthma and COVID-19 | Canadian Paediatric Society. Cps.ca. https://www.cps.ca/en/documents/position/paediatric-asthma-and-covid-19
Reddel H, FitzGerald J, Bateman E, Bacharier L, Becker A, Brusselle G et al (2019) GINA 2019: a fundamental change in asthma management. Eur Respir J 53(6):1901046. https://doi.org/10.1183/13993003.01046-2019
Article
PubMed
Google Scholar
Axelsson M, Ekerljung L, Lundbäck B (2015) The significance of asthma follow-up consultations for adherence to asthma medication, asthma medication beliefs, and asthma control. Nutr Res Pract 2015:1–7. https://doi.org/10.1155/2015/139070
Article
Google Scholar
Meltzer E, Kuna P, Nolte H, Nayak A, LaForce C (2011) Mometasone furoate/formoterol reduces asthma deteriorations and improves lung function. Eur Respir J 39(2):279–289. https://doi.org/10.1183/09031936.00020310
Article
CAS
PubMed
Google Scholar
Hammond C, Kurten M, Kennedy J (2015) Rhinovirus and asthma: a storied history of incompatibility. Curr Allergy Asthma Rep. https://doi.org/10.1007/s11882-014-0502-0
Article
PubMed
PubMed Central
Google Scholar
Lemanske R, Dick E, Swenson C, Vrtis R, Busse W (1989) Rhinovirus upper respiratory infection increases airway hyperreactivity and late asthmatic reactions. J Clin Investig 83(1):1–10. https://doi.org/10.1172/JCI113843
Article
PubMed
PubMed Central
Google Scholar
Ritchie AI, Jackson DJ, Edwards MR, Johnston SL (2016) Airway epithelial orchestration of innate immune function in response to virus infection. A focus on asthma. Ann Am Thorac Soc 13(Supplement 1):S55–S63. https://doi.org/10.1513/AnnalsATS.201507-421MG
Article
PubMed
Google Scholar
Fleming H, Little F, Schnurr D, Avila P, Wong H, Liu J et al (1999) Rhinovirus-16 colds in healthy and in asthmatic subjects. Am J Respir Crit Care Med 160(1):100–108. https://doi.org/10.1164/ajrccm.160.1.9808074
Article
CAS
PubMed
Google Scholar
(220) Peak flow meter vs spirometer. Inofab Health. https://www.inofab.health/blogs/articles/peak-flow-meter-vs-spirometer
Gurbeta L, Badnjevic A, Maksimovic M, Omanovic-Miklicanin E, Sejdic E (2018) A telehealth system for automated diagnosis of asthma and chronical obstructive pulmonary disease. J Am Med Inform Assoc 25(9):1213–1217. https://doi.org/10.1093/jamia/ocy055
Article
PubMed
PubMed Central
Google Scholar
Portnoy J, Waller M, Elliott T (2020) Telemedicine in the era of COVID-19. J Allergy Clin Immunol Pract 8(5):1489–1491. https://doi.org/10.1016/j.jaip.2020.03.008
Article
PubMed
PubMed Central
Google Scholar
Shaker M, Oppenheimer J, Grayson M, Stukus D, Hartog N, Hsieh E et al (2020) COVID-19: pandemic contingency planning for the allergy and immunology clinic. J Allergy Clin Immunol Pract 8(5):1477–1488. https://doi.org/10.1016/j.jaip.2020.03.012
Article
PubMed
PubMed Central
Google Scholar
(2020) The National Asthma Council Australia. Asthma Action Plans. https://www.nationalasthma.org.au/health-professionals/asthma-action-plans
(2020) What to know about asthma. Healthline. https://www.healthline.com/health/asthma